Gradient Boosting Machine Based on PSO for prediction of Leukemia after a Breast Cancer Diagnosis

Basit Öğe Kaydı
dc.authorscopusid56716527100
dc.authorscopusid57222478767
dc.authorscopusid55062117500
dc.contributor.authorDeif, Mohanad A.
dc.contributor.authorHammam, Rania E.
dc.contributor.authorSolyman, Ahmed A. A.
dc.date.accessioned2024-09-11T19:58:07Z
dc.date.available2024-09-11T19:58:07Z
dc.date.issued2021
dc.departmentİstanbul Gelişim Üniversitesien_US
dc.description.abstractThe purpose of this study is to develop an accurate risk predictive model for Chronic Myeloid Leukemia (CML) after an early diagnosis of Breast Cancer (BC). Gradient Boosting Machine (GBM) classification algorithm has been applied to the SEER breast cancer dataset for females diagnosed with BC from 2010 to 2016. A practical Swarm optimizer (PSO) was utilized to optimize the GBM algorithm's hyperparameters to find the SEER dataset's best attributes. Nine attributes were carefully selected to study the growth of CML after a lag time of 6 months following BC's diagnosis. The results revealed that the predictive model could classify patients with breast cancer only and patients with breast cancer with Leukemia by an achieved Accuracy, Sensitivity, and Specificity rates of 98.5 %, 99 %, 97.85 %, respectively. To verify the performance of the proposed algorithm, the accuracy of the suggested GBM classifier model was compared with another state-of-the-art model classifiers KNN (k-Nearest Neighbor), SVM (Support Vector Machine), and RF (Random Forest), which are commonly applied algorithms in most of the existing literature. The results also proved the superior ability of the implemented GBM model Classifier in the classification of breast cancer disease and prediction of patients having Leukemia developed after having breast cancer. These results are promising as they show the integral role of the GBM classifier to classify and predict the tumor with high accuracy and efficiency, which will further help in better cancer diagnosis and treatment of the disease. © 2021, IJASEIT. All rights reserved.en_US
dc.identifier.doi10.18517/ijaseit.11.2.12955
dc.identifier.endpage515en_US
dc.identifier.issn2088-5334en_US
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85109851167en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage508en_US
dc.identifier.urihttps://doi.org/10.18517/ijaseit.11.2.12955
dc.identifier.urihttps://hdl.handle.net/11363/8424
dc.identifier.volume11en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherInsight Societyen_US
dc.relation.ispartofInternational Journal on Advanced Science, Engineering and Information Technologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240903_Gen_US
dc.subjectbreast cancer; chronic myeloid leukemia; classification algorithm; gradient boosting machine; Risk predictive modelen_US
dc.titleGradient Boosting Machine Based on PSO for prediction of Leukemia after a Breast Cancer Diagnosisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu